The <i>CD40LG</i>-<i>CD40</i> axis has emerged as an immune mechanism that transposes depression into the pathogenesis of MASLD, providing a potential target for the intervention of gender-specific metabolic liver disease. Here, CD40 is linked to metabolic dysfunction-associated steatotic liver disease.